These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3916677)

  • 21. Establishing a urinalysis program--prior considerations.
    Hawks RL
    NIDA Res Monogr; 1986; 73():1-4. PubMed ID: 3127716
    [No Abstract]   [Full Text] [Related]  

  • 22. Current developments in drug testing in oral fluid.
    Pil K; Verstraete A
    Ther Drug Monit; 2008 Apr; 30(2):196-202. PubMed ID: 18367980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy in urinalysis.
    Blanke RV
    NIDA Res Monogr; 1986; 73():43-53. PubMed ID: 3127721
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug abuse. Quality control program].
    Ferrara SD; Tedeschi L
    Ann Ist Super Sanita; 1982; 18(4):727-33. PubMed ID: 7188530
    [No Abstract]   [Full Text] [Related]  

  • 25. Implications of drug levels in body fluids: basic concepts.
    Chiang CN; Hawks RL
    NIDA Res Monogr; 1986; 73():62-83. PubMed ID: 3127724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the laboratory in patient management.
    Cohan SL; Taylor RL
    Semin Adolesc Med; 1985 Dec; 1(4):271-7. PubMed ID: 3916464
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug testing programs.
    Willette RE
    NIDA Res Monogr; 1986; 73():5-12. PubMed ID: 3127722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adulterants and substitutes.
    Schauben JL
    Emerg Med Clin North Am; 1990 Aug; 8(3):595-611. PubMed ID: 2201523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Illicit drugs in the environment: Emerging contaminants and indicators of drug abuse.
    Castiglioni S; Zuccato E
    Integr Environ Assess Manag; 2010 Jan; 6(1):186-7. PubMed ID: 20821680
    [No Abstract]   [Full Text] [Related]  

  • 30. The forensic application of testing hair for drugs of abuse.
    Miller ML; Donnelly B; Martz RM
    NIDA Res Monogr; 1997; 167():146-60. PubMed ID: 9243561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choosing a laboratory.
    Willette RE
    NIDA Res Monogr; 1986; 73():13-9. PubMed ID: 3127717
    [No Abstract]   [Full Text] [Related]  

  • 32. Nanoparticle-enhanced fluorescence imaging of latent fingerprints reveals drug abuse.
    Wolfbeis OS
    Angew Chem Int Ed Engl; 2009; 48(13):2268-9. PubMed ID: 19191362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hair analysis: an excellent tool for confirmation of drug abuse.
    Wada M; Nakashima K
    Anal Bioanal Chem; 2006 Jun; 385(3):413-5. PubMed ID: 16715271
    [No Abstract]   [Full Text] [Related]  

  • 34. A stand against drug testing.
    Lampton LM
    Mo Med; 1987 Mar; 84(3):111. PubMed ID: 3509118
    [No Abstract]   [Full Text] [Related]  

  • 35. [Substance-abuse related emergencies--illegal drugs, part II].
    Kinn M; Holzbach R; Pajonk FG
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Jan; 44(1):14-20. PubMed ID: 19115183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Schizophrenia and psychoactive drug abuse: dual diagnostic problem].
    Simoneau I; Villeneuve J; Demers MF; Bouchard RH
    Can J Psychiatry; 2000 Aug; 45(6):572-3. PubMed ID: 10986580
    [No Abstract]   [Full Text] [Related]  

  • 37. New drugs of abuse in North America.
    Haroz R; Greenberg MI
    Clin Lab Med; 2006 Mar; 26(1):147-64, ix. PubMed ID: 16567229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polyneuropathy and myelopathy in N2O abuse within the scope of multiple drug abuse].
    Eichhorn M; Watson M; Wurst F
    Psychiatr Prax; 2001 May; 28(4):204-5. PubMed ID: 11428309
    [No Abstract]   [Full Text] [Related]  

  • 40. Public policy statement on drug testing as a component of addiction treatment and monitoring programs and in other clinical settings.
    J Addict Dis; 2003; 22(3):114-9. PubMed ID: 14621351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.